Intact Investment Management Inc. purchased a new stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) during the fourth quarter, HoldingsChannel.com reports. The firm purchased 2,300 shares of the medical research company’s stock, valued at approximately $1,221,000. A number of other hedge funds also recently made changes to their positions in the stock. Alliance […]
Abbrea Capital LLC decreased its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 2.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,962 shares of the medical research company’s stock after selling 47 shares during the period. Abbrea Capital LLC’s […]
Fisher Asset Management LLC increased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 0.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,572,994 shares of the medical research company’s stock after acquiring an additional 1,917 shares during the quarter. Fisher […]
Summit Financial LLC grew its holdings in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 5.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,814 shares of the medical research company’s stock after purchasing an additional 147 shares during the quarter. […]
Private Wealth Partners LLC lifted its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 1.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 85,131 shares of the medical research company’s stock after purchasing an additional 815 […]
Delta Investment Management LLC trimmed its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 15.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,934 shares of the medical research company’s stock after selling 551 shares during the period. Delta Investment […]
Bahl & Gaynor Inc. lessened its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 2.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,291 shares of the medical research company’s stock after selling 75 shares during the quarter. Bahl & […]
Argonautica Private Wealth Management Inc. decreased its holdings in The Home Depot, Inc. (NYSE:HD – Free Report) by 0.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,582 shares of the home improvement retailer’s stock after selling 48 shares […]
Spinnaker Trust lessened its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 5.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 875 shares of the medical research company’s stock after selling 50 shares during the […]
Anchor Capital Advisors LLC lowered its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 4.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 34,167 shares of the medical research company’s stock after selling 1,762 shares during the quarter. […]
Truist Financial Corp decreased its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 18.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 157,314 shares of the medical research company’s stock after selling 36,454 shares during […]
Argonautica Private Wealth Management Inc. lowered its stake in Oracle Co. (NYSE:ORCL – Free Report) by 0.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,830 shares of the enterprise software provider’s stock after selling 252 shares during the quarter. Oracle makes […]